Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FBXO10 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | SELO | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | KLHL21 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | GRM4 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | CAV1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | LRFN3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | TMX2-CTNND1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | SCAF8 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ACOT13 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | ARL2-SNX15 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |